drugset / Trial / NCT01002508

Influenza Vaccination in Patients With Scleroderma

NCT01002508

Phase 4 Unknown 80 enrolled Tel-Aviv Sourasky Medical Center
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The safety and efficacy of vaccination against influenza in patients with scleroderma is not clear. The objective of this study is to assess its safety and efficacy in 50 patients with scleroderma in comparison with 30 controls

Timeline

Start
2009-11
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine

Indications